ZEISS Medical Ecosystem - Digital Solutions Roll-out

Broad and diversified portfolio with growing share of recurring revenue Share of recurring revenue has advanced steadily over two decades 2021/22 ~46% of total revenue 2002/03 9% of €1,902.8 million ☐ More recurring revenue has allowed for profitable growth and less cyclicality ☐ ☐ ZEISS ZEISS ZEISS Smart Services 150/IEC 27001 We steadily broaden our service offering to complement our product offering and enhance the share of recurring revenue Recurring revenue has reached a new record level of around 46% in 2021/22 (+5 pps yoy) Key components of recurring revenue: Surgical consumables (e.g. intraocular lenses (IOLs), refractive treatment packs, OVDs, viscoelastics, phaco cassettes, drapes etc.) and service Page 11

View entire presentation